CTRI/2022/11/047002进行中（未招募）3 期
A clinical investigation evaluating the risk of occurrence, presence and severity of Diabetic foot neuropathy using VIBRASENSE
CDSIMER0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients with Type 2 Diabetes militus of any duration confirmed by medical records with or without history of diagnosed - DPN
- •2. Patients who who are willing to participate as volunteers and sign the written informed consent
排除标准
- •Patients with:
- •1.Active foot ulceration
- •2.Visual evidence of recently healed foot ulceration
- •3.Lowerlimb amputation of any kind
- •4.Diagnosed PN of any origin other than diabetes
- •5.Alcoholic neuropathy
研究者
相似试验
尚未招募
不适用
CLINICAL STUDY TO EVALUATE THE ROLE OF VAMANA (BIO-PURIFICATORY PROCEDURE OF AYURVEDA) IN PREDIABETES (LATENT DIABETES)CTRI/2021/02/031315EELAKANTA J SAJJANAR
尚未招募
4 期
Study to correlate bubble layer formed in cornea with strength of corneal layers during laser surgery for short sight.CTRI/2020/01/022842ethradhama superspeciality eye hospital
已完成
不适用
Human study to evaluate the effect and safety of oraCMS1 ? (Weissella cibaria CMS1) intake on upper respiratory infections and oral inflammatioKCT0005658Seoul Metropolitan Government Seoul National University Boramae Medical Center90
招募中
3 期
A Study to Evaluate the Efficacy and Safety of Once-weekly Insulin Icodec when Switchingfrom Daily Basal Insulins Compared to Once-daily Insulin Glargine U100 in Adults with Type 2DiabetesCTRI/2024/05/067886ovo Nordisk India Private Limited
招募中
1 期
A Research Study to See How Switching from a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults with Type 2 DiabetesMedDRA version: 21.1Level: LLTClassification code: 10045242Term: Type II diabetes mellitus Class: 10027433Type 2 DiabetesCTIS2023-506084-34-00ovo Nordisk A/S404